Navigation Links
Vermillion and Collaborators Discover Protein Biomarker Associated with Peripheral Artery Disease
Date:8/28/2007

ion, Inc.

Vermillion, Inc. (formerly Ciphergen Biosystems, Inc.) is dedicated to the discovery, development and commercialization of novel high-value diagnostic tests that help physicians diagnose, treat and improve outcomes for patients. Vermillion, along with its prestigious scientific collaborators, has ongoing diagnostic programs in oncology/hematology, cardiology and women's health with an initial focus in ovarian cancer. Based in Fremont, California, more information about Vermillion can be found on the Web at http://www.vermillion.com.

Forward-Looking Statements

This news release contains forward-looking statements that involve significant risks and uncertainties, including those discussed below and others that can be found in Vermillion's Form 10-K for the year ended Dec. 31, 2006, and in Vermillion's periodic reports on Form 10-Q and Form 8-K. Vermillion is providing this information as of the date of this news release and does not undertake any obligation to update any forward-looking statements contained in this document as a result of new information, future events or otherwise.

The scientific information discussed in this news release is preliminary and investigative. No forward-looking statement can be guaranteed and actual results may differ materially from those Vermillion projects. Discovery or identification of new protein biomarkers cannot be guaranteed and movement beyond the clinical validation process to a test that successfully screens patients for PAD is uncertain; consequently, there can be no guarantee that the identification of potential diagnostic markers will be successful or be an appropriate basis for a commercially available test for PAD.


'/>"/>
SOURCE Vermillion, Inc.
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related biology technology :

1. Stratagenes Human cDNA Microarrays: Perform Gene Expression Profiling and Discover New Genes
2. SEESNP DISCOVERY
3. siRNA screening of the cell cycle with two dynamic GFP sensors (from Discovery Matters Issue 1, July 2005)
4. Exploiting the Life Science Data Explosion to Speed New Drug Discovery
5. Rapid, High Throughput Mutation Discovery Using Fluorescent SSCP on the ABI PRISM 3100 and 3100Avant Genetic Analyzers
6. Quantitation of Acrylamide in Food Samples on the Finnigan TSQ Quantum Discovery by LC/APCI-MS/MS
7. Increased Analyte Sensitivity through the Utility of Enhanced Mass-Resolution on the FinniganTSQ Quantum Discovery
8. A new wide field-of-view confocal imaging system and its applications in drug discovery and pathology
9. Document retention policy can get your arms around eDiscovery
10. Finding Safe Harbor in a sea of electronic discovery
11. Quick peeks, Clawback Agreements, and the rules of electronic discovery

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/24/2009)...ATTLE,Nov.24/PRNewswire-FirstCall/--CellTherapeuti...ntatthe21stAnnualPiperJaffrayHealthCareConference....rkPalaceHotel. ,, CTIwillpresentonTuesday,Decem...eaudiowebcastofCTI,spresentationwillbeavailableat ...forreplayafterwards. , ,PiperJaffrayHealthCareCon...
(Date:11/23/2009)...N, Ill. You can think of it as origami very high... Illinois have developed a technique for fabricati...tructures from thin films by coupling photolithogr...y interactions. , The films, only a few microns t...sible with thicker pieces of the same material. ,...
(Date:11/23/2009)... consists of a two-dimensional carbon layer in whi...ttice, resembling a honeycomb. Carbon nanotubes ar... graphene sheets form graphite. Graphene boasts so...ear-resistant, an excellent thermal conductor, and...ess and ductility. In addition, graphene is imperm...
(Date:11/23/2009)...SSISSAUGA,ON,Nov.23/PRNewswire-FirstCall/-YMBioSci...uctdevelopmentcompanythatidentifiesandadvancesadiv...riousstagesofdevelopment,todayreportedthatCytopia(...luatingCYT387,apotent,orally-administeredJAK1/JAK2...chester,Minnesota.AproposaltomergeCytopiaintoYMhas...
Breaking Biology Technology:Water droplets direct self-assembly process in thin-film materials 2Polymer with honeycomb structure 2YM BIOSCIENCES REPORTS FIRST PATIENT IN PHASE I/II TRIAL OF JAK1/JAK2 INHIBITOR, CYT387 ENROLLED BY CYTOPIA 2YM BIOSCIENCES REPORTS FIRST PATIENT IN PHASE I/II TRIAL OF JAK1/JAK2 INHIBITOR, CYT387 ENROLLED BY CYTOPIA 3YM BIOSCIENCES REPORTS FIRST PATIENT IN PHASE I/II TRIAL OF JAK1/JAK2 INHIBITOR, CYT387 ENROLLED BY CYTOPIA 4
...-dose cohorts plus data from subsequent higher-dos..., Calif., March 18 InterMune, Inc. (Nasdaq: ITM...ical study of ITMN-191 (R7227) in combination with...ferred to as the INFORM-1 study, has been accepted... at the 44th Annual Meeting of the European Associ...
.... Wright, Co-Chair of the Alliance for Biosecurity...ied today before the House Labor, Health and Human...ee on the critical importance of developing drugs,... to protect Americans from bioterrorism and other ... countermeasures for many of the chemical, biologi...
...Marin Pharmaceutical Inc. (Nasdaq: BMRN ) announ...authorization (CTA) for BMN 110 or N-acetylgalacto...ment of the lysosomal storage disorder Mucopolysac...me, has been accepted by the United Kingdom Medici...A). BioMarin expects to initiate a Phase 1/2 clini...
Other Biology Technology:INFORM-1 Interim Results Accepted for Late-Breaker Presentation at the 44th Annual Meeting of the European Association for the Study of the Liver (EASL) 2INFORM-1 Interim Results Accepted for Late-Breaker Presentation at the 44th Annual Meeting of the European Association for the Study of the Liver (EASL) 3INFORM-1 Interim Results Accepted for Late-Breaker Presentation at the 44th Annual Meeting of the European Association for the Study of the Liver (EASL) 4Alliance for Biosecurity Testifies Before Congress on Funding for Medical Countermeasure Development 2BioMarin's Clinical Trial Application for GALNS for Morquio A Syndrome Accepted by the MHRA 2BioMarin's Clinical Trial Application for GALNS for Morquio A Syndrome Accepted by the MHRA 3BioMarin's Clinical Trial Application for GALNS for Morquio A Syndrome Accepted by the MHRA 4
(Date:11/24/2009)...that may help gut bacteria bind to the gastrointes...c producers to identify strains that are likely to... to interact with cells lining the gut to have a b...n the gut they are more likely to stick around lon...e Juge from the Institute of Food Research. IFR i...
(Date:11/24/2009)...dical Toxicology (ACMT) have signed an agreement t...f Medical Toxicology (JMT), the official journal ...iously published by the University of Pennsylvania...an international, peer-reviewed journal, is dedica...al toxicology. The quarterly journal focuses on t...
(Date:11/24/2009)... of debate. A high-profile study a few years ago s...carbon from trees and leaves, evidence for a very ...systems. , But new research from the University ... Algae provide a much richer diet for fish and oth...his week in the Proceedings of the National Acade...
Breaking Biology News(10 mins):A sticky solution for identifying effective probiotics 2Springer and the American College of Medical Toxicology to work together 2Fish food fight: Fish don't eat trees after all, says new study 2Fish food fight: Fish don't eat trees after all, says new study 3Minorities Less Likely to Have Blood Pressure Under Control 58190 1Minorities Less Likely to Have Blood Pressure Under Control 58190 2Minorities Less Likely to Have Blood Pressure Under Control 58190 3The Hospital of Central Connecticut Selects Ingenious Med for Inpatient Practice Management 58185 1The Hospital of Central Connecticut Selects Ingenious Med for Inpatient Practice Management 58185 2The Hospital of Central Connecticut Selects Ingenious Med for Inpatient Practice Management 58185 3Aviva Family and Childrens Services Hosts Rededication Ceremony of the Newly Renovated Wallis Annenberg Center 58180 1Aviva Family and Childrens Services Hosts Rededication Ceremony of the Newly Renovated Wallis Annenberg Center 58180 2
...ilian personnel from the U.S. Armed Forces, as wel...aw enforcement and other first-responder personnel...dia have been encouraged to register and attend th...PED VII). The event will be held at Stafford Regio...uring May 19-21. , , The demonstration, which is ...
..., University of Alabama at Birmingham professor of...Prize for Outstanding Innovation in Life Sciences....salutes Weaver,s achievements in advancing underst...ough T cell research. , According to Weaver, our...and cancer, but when T cells overreact and turn on...
...ng diverse forests for multiple uses is important ...dy conducted in southwestern Oregon provides fores...en managing land for a variety objectives that may...te level of wood production with some wildlife hab...s cover and forage for a wider variety of wildlife...
Other Biology News:Demonstration Features Commercial Technology for Combating Terrorism 2UAB professor receives HudsonAlpha Innovation Prize 2Managing Douglas-fir forests for diversity 2
PARP Cleavage Immunoblotting Assay Kit from Upstate
...o-Sequencing is designed to aid sequence analysis ...ning sites (MCS) of M13 phage vectors (mp18/19) or...). The kit is used to create nested unidirectional...y moving the primer binding site on the vector clo...
MaxArray Rat Brain Tissue Slides from Invitrogen
...ion Kit, 100 reactions. Prepare circular DNA templ...ram quantities of template DNA from picogram amoun... for cycle sequencing without purification.Amplify...es, plaques, or purified circular (plasmid or M13)...
Biology Products: